Resilience: Biological Basis and Clinical Significance - A Perspective Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
- PMID: 36346720
- PMCID: PMC9589704
- DOI: 10.14283/jfa.2022.62
Resilience: Biological Basis and Clinical Significance - A Perspective Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
Abstract
The Resilience is a construct receiving growing attention from the scientific community in geriatrics and gerontology. Older adults show extremely heterogeneous (and often unpredictable) responses to stressors. Such heterogeneity can (at least partly) be explained by differences in resilience (i.e., the capacity of the organism to cope with stressors). The International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force met in Boston (MA,USA) on April 20, 2022 to discuss the biological and clinical significance of resilience in older adults. The identification of persons with low resilience and the prompt intervention in this at-risk population may be critical to develop and implement preventive strategies against adverse events. Unfortunately, to date, it is still challenging to capture resilience, especially due to its dynamic nature encompassing biological, clinical, subjective, and socioeconomic factors. Opportunities to dynamically measure resilience were discussed during the ICFSR Task Force meeting, emphasizing potential biomarkers and areas of intervention. This article reports the results of the meeting and may serve to support future actions in the field.
Keywords: Aging; biomarkers; geroscience; older adults; translational research.
Conflict of interest statement
The Task Force was partially funded by registration fees from industrial participants. These corporations placed no restrictions on this work. Dr. Rooks is employees of Novartis Institutes for BioMedical Research. Dr. Vellas is an investigator in clinical trials sponsored by the Toulouse University Hospital (Inspire Geroscience Program). Dr. Fielding reported grants from National Institutes of Health, grants from USDA Agricultural Research Service, grants, personal fees and other from Axcella Health, Juvicell, Inside Tracker, grants and personal fees from Biophytis, personal fees from Amazentis, Nestlé and Pfizer, outside the submitted work. No conflict of interest declared by the other authors.
Figures


Similar articles
-
Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force.J Frailty Aging. 2022;11(2):135-142. doi: 10.14283/jfa.2022.30. J Frailty Aging. 2022. PMID: 35441189 Free PMC article.
-
Identifying Biomarkers for Biological Age: Geroscience and the ICFSR Task Force.J Frailty Aging. 2021;10(3):196-201. doi: 10.14283/jfa.2021.5. J Frailty Aging. 2021. PMID: 34105701 Free PMC article.
-
Assessment and Management of Appetite Loss in Older Adults: An ICFSR Task Force Report.J Frailty Aging. 2023;12(1):1-6. doi: 10.14283/jfa.2022.64. J Frailty Aging. 2023. PMID: 36629077
-
Intrinsic capacity and resilience: Taking frailty to the next level.J Geriatr Oncol. 2023 Mar;14(2):101421. doi: 10.1016/j.jgo.2022.101421. Epub 2023 Jan 17. J Geriatr Oncol. 2023. PMID: 36657249 Review.
-
Physical frailty and sarcopenia (PF&S): a point of view from the industry.Aging Clin Exp Res. 2017 Feb;29(1):69-74. doi: 10.1007/s40520-016-0710-7. Epub 2017 Feb 3. Aging Clin Exp Res. 2017. PMID: 28160253 Review.
Cited by
-
Physical Resilience as a Predictor of Lifespan and Late-Life Health in Genetically Heterogeneous Mice.J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1):glad207. doi: 10.1093/gerona/glad207. J Gerontol A Biol Sci Med Sci. 2024. PMID: 37701988 Free PMC article.
-
From frailty to resilience: exploring adaptive capacity and reserve in older adults-a narrative review.Front Aging. 2025 Jul 1;6:1520842. doi: 10.3389/fragi.2025.1520842. eCollection 2025. Front Aging. 2025. PMID: 40665991 Free PMC article. Review.
-
Frailty index in the Colonias of the Rio Grande Valley: health related quality of life and resilience.Front Med (Lausanne). 2023 Nov 27;10:1240494. doi: 10.3389/fmed.2023.1240494. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38089876 Free PMC article.
-
Negative effects of lifespan extending intervention on resilience in mice.PLoS One. 2024 Nov 21;19(11):e0312440. doi: 10.1371/journal.pone.0312440. eCollection 2024. PLoS One. 2024. PMID: 39570905 Free PMC article.
-
Framework for a short muscle function battery using electronic handgrip dynamometry and accelerometry in older adults.J Frailty Aging. 2025 Jun;14(3):100045. doi: 10.1016/j.tjfa.2025.100045. Epub 2025 Apr 18. J Frailty Aging. 2025. PMID: 40252224 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous